SIRT1 Deficiency, Specifically in Fibroblasts, Decreases Apoptosis Resistance and Is Associated with Resolution of Lung-Fibrosis.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
02 07 2020
Historique:
received: 07 05 2020
revised: 16 06 2020
accepted: 29 06 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 20 4 2021
Statut: epublish

Résumé

In contrast to normal regenerating tissue, resistance to Fas- and FasL-positive T cell-induced apoptosis were detected in myofibroblasts from fibrotic-lungs of humans and mice following bleomycin (BLM) exposure. In this study we show, decreased FLIP expression in lung-tissues with resolution of BLM-induced fibrosis and in isolated-lung fibroblasts, with decreased resistance to apoptosis. Using a FLIP-expression vector or a shFLIP-RNA, we further confirmed the critical need for FLIP to regain/lose susceptibility of fibrotic-lung myofibroblast to Fas-induced apoptosis. Our study further show that FLIP is regulated by SIRT1 (Sirtuin 1) deacetylase. Chimeric mice, with SIRT1-deficiency in deacetylase domain (

Identifiants

pubmed: 32630813
pii: biom10070996
doi: 10.3390/biom10070996
pmc: PMC7407379
pii:
doi:

Substances chimiques

CASP8 and FADD-Like Apoptosis Regulating Protein 0
CFLAR protein, human 0
MIRN34 microRNA, human 0
MicroRNAs 0
RNA, Small Interfering 0
Bleomycin 11056-06-7
SIRT1 protein, human EC 3.5.1.-
Sirtuin 1 EC 3.5.1.-
Xrcc6 protein, human EC 3.6.4.12
Ku Autoantigen EC 4.2.99.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pulm Pharmacol Ther. 2007;20(6):642-9
pubmed: 17035056
Biochem Biophys Res Commun. 2017 May 13;486(4):1021-1026
pubmed: 28365154
Mol Cancer Ther. 2010 Jan;9(1):246-56
pubmed: 20053768
Cell Death Differ. 2007 Dec;14(12):2058-67
pubmed: 17885668
RNA Biol. 2014;11(11):1347-54
pubmed: 25483038
Blood Cancer J. 2014 May 02;4:e207
pubmed: 24786391
Nat Rev Mol Cell Biol. 2015 Apr;16(4):258-64
pubmed: 25549891
Inflammation. 2012 Oct;35(5):1732-41
pubmed: 22707284
Exp Lung Res. 2015;41(8):422-34
pubmed: 26151196
Ann Rheum Dis. 2016 Jan;75(1):226-33
pubmed: 25180292
Mol Cancer Ther. 2008 Jun;7(6):1615-23
pubmed: 18566232
Am J Respir Cell Mol Biol. 2012 Sep;47(3):271-9
pubmed: 22582174
Am J Respir Cell Mol Biol. 2007 Mar;36(3):270-5
pubmed: 16990614
Eur Respir J. 2014 May;43(5):1448-58
pubmed: 24603818
Eur Respir J. 2002 Aug;20(2):359-68
pubmed: 12212968
Am J Physiol Lung Cell Mol Physiol. 2006 Apr;290(4):L790-L796
pubmed: 16306138
J Autoimmun. 2015 May;59:67-76
pubmed: 25812467
FASEB J. 2016 Dec;30(12):3942-3960
pubmed: 27591175
Int J Biochem Cell Biol. 2013 Mar;45(3):711-23
pubmed: 23247197
Am J Pathol. 2005 Feb;166(2):399-407
pubmed: 15681824
Am J Respir Cell Mol Biol. 2009 Feb;40(2):231-8
pubmed: 18676775
Int J Exp Pathol. 2002 Jun;83(3):111-9
pubmed: 12383190
Toxicol Appl Pharmacol. 2015 Dec 1;289(2):163-76
pubmed: 26435214
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20460-5
pubmed: 18077384
Int J Mol Sci. 2020 Mar 23;21(6):
pubmed: 32210149
Cell Death Dis. 2013 May 02;4:e621
pubmed: 23640463
J Pharmacol Exp Ther. 2010 Nov;335(2):266-72
pubmed: 20719940
Cell. 2001 Oct 19;107(2):137-48
pubmed: 11672522
Am J Respir Crit Care Med. 2014 May 15;189(10):1161-72
pubmed: 24641682
Cell. 2006 Jul 28;126(2):257-68
pubmed: 16873059
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6
pubmed: 18755897
Am J Physiol Lung Cell Mol Physiol. 2017 Mar 01;312(3):L415-L424
pubmed: 27979858
Am J Pathol. 2017 May;187(5):1016-1034
pubmed: 28273432
Cell Metab. 2005 Jul;2(1):67-76
pubmed: 16054100
Curr Opin Rheumatol. 2010 Nov;22(6):683-9
pubmed: 20693906
Sci Transl Med. 2014 Apr 9;6(231):231ra47
pubmed: 24718857
Cell Death Differ. 2012 Aug;19(8):1317-27
pubmed: 22322857
Oncotarget. 2017 Sep 21;8(60):102640-102652
pubmed: 29254277
Biochim Biophys Acta. 2016 Oct;1864(10):1372-401
pubmed: 27296530
Oncotarget. 2016 Mar 22;7(12):13538-50
pubmed: 26646449
Ann Am Thorac Soc. 2015 Dec;12(12):S222-7
pubmed: 26653202
Mol Ther. 2013 Apr;21(4):825-33
pubmed: 23403494

Auteurs

Raanan Bulvik (R)

Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel.

Raphael Breuer (R)

Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel.
Department of Pathology and Laboratory Medicine, 670 Albany St, 4th Floor, Boston University School of Medicine, Boston, MA 02118, USA.

Mona Dvir-Ginzberg (M)

Institute of Dental Sciences, Faculty of Dental Medicine, Hebrew University-Hadassah, POB 12065, Jerusalem 9112102, Israel.

Eli Reich (E)

Institute of Dental Sciences, Faculty of Dental Medicine, Hebrew University-Hadassah, POB 12065, Jerusalem 9112102, Israel.

Neville Berkman (N)

Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel.

Shulamit B Wallach-Dayan (SB)

Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH